72 related articles for article (PubMed ID: 3911479)
1. Protein C antigen levels in major abdominal surgery: relationships to deep vein thrombosis, malignancy and treatment with stanozolol.
Blamey SL; Lowe GD; Bertina RM; Kluft C; Sue-Ling HM; Davies JA; Forbes CD
Thromb Haemost; 1985 Oct; 54(3):622-5. PubMed ID: 3911479
[TBL] [Abstract][Full Text] [Related]
2. Plasma beta-thromboglobulin, fibrinopeptide A and B beta 15-42 antigen in relation to postoperative DVT, malignancy and stanozolol treatment.
Douglas JT; Blamey SL; Lowe GD; Carter DC; Forbes CD
Thromb Haemost; 1985 Apr; 53(2):235-8. PubMed ID: 2410995
[TBL] [Abstract][Full Text] [Related]
3. A double-blind trial of intramuscular stanozolol in the prevention of postoperative deep vein thrombosis following elective abdominal surgery.
Blamey SL; McArdle BM; Burns P; Carter DC; Lowe GD; Forbes CD
Thromb Haemost; 1984 Feb; 51(1):71-4. PubMed ID: 6539002
[TBL] [Abstract][Full Text] [Related]
4. Effects of oral stanozolol used in the prevention of postoperative deep vein thrombosis on fibrinolytic activity.
Sue-Ling HM; Davies JA; Prentice CR; Verheijen JH; Kluft C
Thromb Haemost; 1985 Feb; 53(1):141-2. PubMed ID: 3873118
[TBL] [Abstract][Full Text] [Related]
5. Hemostatic effects of oral contraceptives in women who developed deep-vein thrombosis while using oral contraceptives.
Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Koster T; Bertina RM; Vandenbroucke JP
Thromb Haemost; 1998 Sep; 80(3):382-7. PubMed ID: 9759614
[TBL] [Abstract][Full Text] [Related]
6. [Protein C dynamics in peripheral arterial occlusive diseases and myocardial infarction: association of homozygous protein C deficiency with heterozygous dysplasminogenemia found among patients with deep vein thrombosis].
Manabe S
Nihon Geka Gakkai Zasshi; 1986 Feb; 87(2):220-30. PubMed ID: 3754930
[TBL] [Abstract][Full Text] [Related]
7. Incidence, natural history and risk factors of deep vein thrombosis in elective knee arthroscopy.
Delis KT; Hunt N; Strachan RK; Nicolaides AN
Thromb Haemost; 2001 Sep; 86(3):817-21. PubMed ID: 11583313
[TBL] [Abstract][Full Text] [Related]
8. Fibrinolytic parameters in patients undergoing total hip replacement: relationship with the development of asymptomatic deep vein thrombosis and diagnostic usefulness of venous occlusion.
Trotti R; Siragusa S; Rondanelli M; Chezzi L; Citterio A; Melzi d'Eril GV; Piovella F
Haematologica; 1997; 82(2):178-81. PubMed ID: 9175322
[TBL] [Abstract][Full Text] [Related]
9. Blood coagulation and thrombosis in patients with ovarian malignancy.
von Tempelhoff GF; Dietrich M; Niemann F; Schneider D; Hommel G; Heilmann L
Thromb Haemost; 1997 Mar; 77(3):456-61. PubMed ID: 9065993
[TBL] [Abstract][Full Text] [Related]
10. Prevention of postoperative deep vein thrombosis in cancer patients. A randomized trial with low molecular weight heparin (CY 216).
Marassi A; Balzano G; Mari G; D'Angelo SV; Della Valle P; Di Carlo V; D'Angelo A
Int Surg; 1993; 78(2):166-70. PubMed ID: 8394842
[TBL] [Abstract][Full Text] [Related]
11. Relationship between factor XII, von Willebrand factor and postoperative deep vein thrombosis.
Nilsson T; Mellbring G; Hedner U
Acta Chir Scand; 1986 May; 152():347-9. PubMed ID: 3090810
[TBL] [Abstract][Full Text] [Related]
12. Prediction of deep vein thrombosis after elective hip replacement surgery by preoperative clinical and haemostatic variables: the ECAT DVT Study. European Concerted Action on Thrombosis.
Lowe GD; Haverkate F; Thompson SG; Turner RM; Bertina RM; Turpie AG; Mannucci PM
Thromb Haemost; 1999 Jun; 81(6):879-86. PubMed ID: 10404761
[TBL] [Abstract][Full Text] [Related]
13. Postoperative changes in the plasmatic levels of tissue-type plasminogen activator and its fast-acting inhibitor--relationship to deep vein thrombosis and influence of prophylaxis.
Páramo JA; Alfaro MJ; Rocha E
Thromb Haemost; 1985 Oct; 54(3):713-6. PubMed ID: 3937269
[TBL] [Abstract][Full Text] [Related]
14. Protein C, an anticoagulant protein, is increased in healthy volunteers and surgical patients after treatment with stanozolol.
Kluft C; Bertina RM; Preston FE; Malia RG; Blamey SL; Lowe GD; Forbes CD
Thromb Res; 1984 Feb; 33(3):297-304. PubMed ID: 6546815
[TBL] [Abstract][Full Text] [Related]
15. Preoperative immunonutrition suppresses perioperative inflammatory response in patients with major abdominal surgery-a randomized controlled pilot study.
Giger U; Büchler M; Farhadi J; Berger D; Hüsler J; Schneider H; Krähenbühl S; Krähenbühl L
Ann Surg Oncol; 2007 Oct; 14(10):2798-806. PubMed ID: 17632760
[TBL] [Abstract][Full Text] [Related]
16. Protein C inhibitor and other components of the protein C pathway in patients with acute deep vein thrombosis during heparin treatment.
Tabernero D; España F; Vicente V; Estellés A; Gilabert J; Aznar J
Thromb Haemost; 1990 Jun; 63(3):380-2. PubMed ID: 2169656
[TBL] [Abstract][Full Text] [Related]
17. Treatment of hereditary protein C deficiency with stanozolol.
Broekmans AW; Conard J; van Weyenberg RG; Horellou MH; Kluft C; Bertina RM
Thromb Haemost; 1987 Feb; 57(1):20-4. PubMed ID: 3590078
[TBL] [Abstract][Full Text] [Related]
18. Prolonged thromboprophylaxis with dalteparin after surgical treatment of achilles tendon rupture: a randomized, placebo-controlled study.
Lapidus LJ; Rosfors S; Ponzer S; Levander C; Elvin A; Lärfars G; de Bri E
J Orthop Trauma; 2007 Jan; 21(1):52-7. PubMed ID: 17211270
[TBL] [Abstract][Full Text] [Related]
19. The clinical course of deep-vein thrombosis. Prospective long-term follow-up of 528 symptomatic patients.
Prandoni P; Villalta S; Bagatella P; Rossi L; Marchiori A; Piccioli A; Bernardi E; Girolami B; Simioni P; Girolami A
Haematologica; 1997; 82(4):423-8. PubMed ID: 9299855
[TBL] [Abstract][Full Text] [Related]
20. [Clinical risk factors for deep vein thrombosis after total hip and knee arthroplasty].
Guan ZP; Lü HS; Chen YZ; Song YN; Qin XL; Jiang J
Zhonghua Wai Ke Za Zhi; 2005 Oct; 43(20):1317-20. PubMed ID: 16271243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
